Published in Gut on November 01, 1991
Helicobacter pylori. Clin Microbiol Rev (1997) 9.22
Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev (2006) 7.72
CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J Clin Pathol (1994) 3.48
Pathogenicity of Helicobacter pylori: a perspective. Infect Immun (1993) 3.08
Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut (1998) 1.82
Purification of Helicobacter pylori superoxide dismutase and cloning and sequencing of the gene. Infect Immun (1993) 1.78
Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview. CMAJ (1994) 1.78
Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses. Clin Microbiol Rev (2006) 1.73
Antrum- and corpus mucosa-infiltrating CD4(+) lymphocytes in Helicobacter pylori gastritis display a Th1 phenotype. Infect Immun (1998) 1.67
Immune responses of specific-pathogen-free mice to chronic Helicobacter pylori (strain SS1) infection. Infect Immun (1998) 1.61
Helicobacter mustelae isolation from feces of ferrets: evidence to support fecal-oral transmission of a gastric Helicobacter. Infect Immun (1992) 1.51
Cloning and genetic characterization of Helicobacter pylori catalase and construction of a catalase-deficient mutant strain. J Bacteriol (1996) 1.35
Effect of eradication of Helicobacter pylori on gastric juice ascorbic acid concentrations. Gut (1993) 1.32
Relation between Helicobacter pylori infection and gastrointestinal symptoms and syndromes. Gut (1997) 1.24
Induction of maturation and cytokine release of human dendritic cells by Helicobacter pylori. Infect Immun (2004) 1.21
Microsatellite instability in gastric intestinal metaplasia in patients with and without gastric cancer. Am J Pathol (2000) 1.20
Effect of Helicobacter pylori and its eradication on gastric juice ascorbic acid. Gut (1994) 1.19
The relation between gastric vitamin C concentrations, mucosal histology, and CagA seropositivity in the human stomach. Gut (1998) 1.13
Antigen recognition during progression from acute to chronic infection with a cagA-positive strain of Helicobacter pylori. Infect Immun (1996) 1.13
A conventional beagle dog model for acute and chronic infection with Helicobacter pylori. Infect Immun (1999) 1.09
Helicobacter pylori represses proton pump expression and inhibits acid secretion in human gastric mucosa. Gut (2010) 1.08
Helicobacter pylori related hypergastrinaemia is the result of a selective increase in gastrin 17. Gut (1993) 1.04
Seroconversion and seroreversion in IgG antibodies to Helicobacter pylori: a serology based prospective cohort study. J Epidemiol Community Health (2000) 1.02
Effect of Helicobacter pylori infection on gastric epithelial cell proliferation. World J Gastroenterol (2000) 1.01
Acute gastritis with hypochlorhydria: report of 35 cases with long term follow up. Gut (2000) 1.00
Gastrin and somatostatin in Helicobacter pylori infected antral mucosa. Gut (1994) 1.00
How Helicobacter pylori infection controls gastric acid secretion. J Gastroenterol (2012) 0.99
Occurrence of gastric ulcers in gnotobiotic piglets colonized by Helicobacter pylori. Infect Immun (1995) 0.95
Serum ferritin, vitamin B(12), folate, and zinc levels in children infected with Helicobacter pylori. Dig Dis Sci (2007) 0.94
Expression of cyclooxygenase-2 in human neutrophils activated by Helicobacter pylori water-soluble proteins: possible involvement of NF-kappaB and MAP kinase signaling pathway. Dig Dis Sci (2001) 0.93
Experimental Helicobacter pylori infection induces antral gastritis and gastric mucosa-associated lymphoid tissue in guinea pigs. Infect Immun (1998) 0.93
Gastric cancer and Helicobacter pylori infection. J Clin Pathol (1993) 0.92
Vitamin C supplementation does not protect L-gulono-gamma-lactone oxidase-deficient mice from Helicobacter pylori-induced gastritis and gastric premalignancy. Int J Cancer (2008) 0.88
B-cell and T-cell immune responses to experimental Helicobacter pylori infection in humans. Infect Immun (2005) 0.87
In vitro characterization of the anti-bacterial activity of SQ109 against Helicobacter pylori. PLoS One (2013) 0.87
Helicobacter heilmannii-associated gastritis: clinicopathologic findings and comparison with Helicobacter pylori-associated gastritis. J Korean Med Sci (2007) 0.86
Age dependent hypergastrinaemia in children with Helicobacter pylori gastritis--evidence of early acquisition of infection. Gut (1995) 0.86
Vitamin C, gastritis, and gastric disease: a historical review and update. Dig Dis Sci (2012) 0.86
Immunohistochemical study of lymphocyte populations infiltrating the gastric mucosa of beagle dogs experimentally infected with Helicobacter pylori. Infect Immun (2000) 0.85
Increased gastric IL-1β concentration and iron deficiency parameters in H. pylori infected children. PLoS One (2013) 0.85
Helicobacter pylori water-soluble surface proteins activate human neutrophils and up-regulate expression of CXC chemokines. Dig Dis Sci (2000) 0.85
Helicobacter felis infection is associated with lymphoid follicular hyperplasia and mild gastritis but normal gastric secretory function in cats. Infect Immun (2000) 0.84
Helicobacter pylori, musings from the epidemiologic armchair. Epidemiol Infect (1992) 0.84
Iron status and Helicobacter pylori infection in symptomatic children: an international multi-centered study. PLoS One (2013) 0.83
Role of Helicobacter pylori surface structures in bacterial interaction with macrophages. Gut (1997) 0.83
Helicobacter pylori infection affects immune responses following vaccination of typhoid-naive U.S. adults with attenuated Salmonella typhi oral vaccine CVD 908-htrA. J Infect Dis (2013) 0.82
Helicobacter pylori SabA adhesin evokes a strong inflammatory response in human neutrophils which is down-regulated by the neutrophil-activating protein. Med Microbiol Immunol (2006) 0.82
Detection of anti-Helicobacter pylori antibodies in serum and duodenal fluid in peptic gastroduodenal disease. World J Gastroenterol (2004) 0.82
Increased macrophage infiltration of gastric mucosa in Helicobacter pylori-infected children. Dig Dis Sci (2000) 0.81
Unintended consequences of Helicobacter pylori infection in children in developing countries: iron deficiency, diarrhea, and growth retardation. Gut Microbes (2013) 0.81
Efficacy of the antimicrobial peptide TP4 against Helicobacter pylori infection: in vitro membrane perturbation via micellization and in vivo suppression of host immune responses in a mouse model. Oncotarget (2015) 0.80
Eradication of Helicobacter pylori: therapies and clinical implications. Postgrad Med J (1992) 0.80
Transmission of Helicobacter pylori. Postgrad Med J (1999) 0.79
Helicobacter pylori-induced gastric pathology: insights from in vivo and ex vivo models. Dis Model Mech (2017) 0.78
Presence of terminal EPIYA phosphorylation motifs in Helicobacter pylori CagA contributes to IL-8 secretion, irrespective of the number of repeats. PLoS One (2013) 0.78
Helicobacter pylori virulence factors affecting gastric proton pump expression and acid secretion. Am J Physiol Gastrointest Liver Physiol (2015) 0.78
Helicobacter pylori infection and typhoid fever in Jakarta, Indonesia. Epidemiol Infect (2006) 0.77
Can Helicobacter pylori infection influence human reproduction? World J Gastroenterol (2014) 0.77
The inflammatory response in CD1 mice shortly after infection with a CagA+/VacA+ Helicobacter pylori strain. Clin Exp Immunol (1999) 0.77
Interleukin-1 gene polymorphisms in chronic gastritis patients infected with Helicobacter pylori as risk factors of gastric cancer development. Arch Immunol Ther Exp (Warsz) (2013) 0.76
Vitamin C and gastric cancer: supplements for some or fruit for all? Gut (1996) 0.75
The British Society of Gastroenterology Diamond Jubilee. March 1997. Gut (1997) 0.75
Helicobacter pylori: trick or treat? J R Soc Med (1994) 0.75
Helicobacter pylori CagA induced interleukin-8 secretion in gastric epithelial cells. Gastroenterol Hepatol Bed Bench (2016) 0.75
Helicobacter pylori seroconversion in asymptomatic blood donors: a five-year follow-up. Dig Dis Sci (2000) 0.75
A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots. Anal Biochem (1984) 22.53
Attempt to fulfil Koch's postulates for pyloric Campylobacter. Med J Aust (1985) 10.75
Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology (1988) 8.27
Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol (1987) 7.09
Epidemic gastritis with hypochlorhydria. Gastroenterology (1979) 2.65
Antibody response of patients against a 120 kDa surface protein of Campylobacter pylori. Zentralbl Bakteriol Mikrobiol Hyg A (1988) 2.18
Iatrogenic Campylobacter pylori infection is a cause of epidemic achlorhydria. Am J Gastroenterol (1988) 1.97
Increased incidence of Campylobacter pylori infection in gastroenterologists: further evidence to support person-to-person transmission of C. pylori. Scand J Gastroenterol (1989) 1.70
Elimination of Helicobacter pylori under treatment with omeprazole. Z Gastroenterol (1990) 1.60
Ascorbic acid in the human stomach. Gastroenterology (1989) 1.58
Phlegmonous gastritis. Gastroenterology (1975) 1.53
Epidemic hypochlorhydria. Br Med J (Clin Res Ed) (1985) 1.47
Ascorbic acid: a factor concentrated in human gastric juice. Clin Sci (Lond) (1989) 1.36
Acute presentation of Campylobacter pylori gastritis. Am J Gastroenterol (1988) 1.18
Gastric juice ascorbic acid: effects of disease and implications for gastric carcinogenesis. Am J Clin Nutr (1991) 1.18
Campylobacter-like organisms and acute purulent gastritis. Lancet (1986) 1.05
Does omeprazole improve antimicrobial therapy directed towards gastric Campylobacter pylori in patients with antral gastritis? A pilot study. Scand J Gastroenterol Suppl (1989) 1.03
Seroepidemiological study of the immune response to Campylobacter pylori in potential risk groups. Eur J Clin Microbiol Infect Dis (1989) 1.00
cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci U S A (1996) 16.69
Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet (1980) 10.23
Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet (1986) 10.07
The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39
A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology (1997) 7.72
The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet (1993) 6.84
Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet (1991) 6.73
Screening dyspepsia by serology to Helicobacter pylori. Lancet (1991) 6.13
Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet (1994) 5.86
Validation of a rapid whole blood test for diagnosing Helicobacter pylori infection. BMJ (1997) 5.80
Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet (1999) 5.36
Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HpSA European study group. Lancet (1999) 5.27
Analyses of the cag pathogenicity island of Helicobacter pylori. Mol Microbiol (1998) 5.07
Early endoscopy of oesophagus, stomach, and duodenal bulb in patients with haematemesis and melaena. Br Med J (1973) 4.84
Prevention of neural tube defects. Lancet (1993) 4.83
Simplified techniques for identifying Campylobacter pyloridis. J Clin Pathol (1986) 4.74
Systemic and local antibody responses to gastric Campylobacter pyloridis in non-ulcer dyspepsia. Gut (1986) 4.47
Gastric cancer: a curable disease in Britain. BMJ (1993) 4.24
Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet (1983) 4.02
Direct polymerase chain reaction test for detection of Helicobacter pylori in humans and animals. J Clin Microbiol (1991) 3.91
Vitamin dificiencies and neural tube defects. Arch Dis Child (1976) 3.87
Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut (1991) 3.82
Gastric dysplasia: the Padova international classification. Am J Surg Pathol (2000) 3.66
Apparent prevention of neural tube defects by periconceptional vitamin supplementation. Arch Dis Child (1981) 3.45
Malnutrition in surgical patients. An unrecognised problem. Lancet (1977) 3.37
Campylobacter pyloridis--a new factor in peptic ulcer disease? Gut (1986) 3.26
Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies in the UK. Lancet (2000) 3.23
Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis. J Clin Pathol (1987) 3.21
Prevention of neural-tube defects. Lancet (1997) 3.11
Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative. J Clin Pathol (1997) 2.98
Lymphocytic gastritis--relationship to Campylobacter pylori infection. J Pathol (1988) 2.88
Acute folate deficiency in surgical patients on aminoacid/ethanol intravenous nutrition. Lancet (1975) 2.86
Oesophageal achalasia in adolescent women mistaken for anorexia nervosa. BMJ (1992) 2.78
Venous air embolism associated with removal of central venous catheter. BMJ (1992) 2.75
Reflux gastritis: distinct histopathological entity? J Clin Pathol (1986) 2.73
Apparent prevention of neural tube defects by periconceptional vitamin supplementation. 1981. Int J Epidemiol (2011) 2.68
Expression of 120 kilodalton protein and cytotoxicity in Helicobacter pylori. J Clin Pathol (1992) 2.60
Identification of Helicobacter pylori DNA in the mouths and stomachs of patients with gastritis using PCR. J Clin Pathol (1993) 2.60
Observer variation in the histological grading of rectal carcinoma. J Clin Pathol (1983) 2.59
Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis. Gut (1990) 2.58
Prevention of neural tube defect recurrences in Yorkshire: final report. Lancet (1989) 2.48
Identification of a pathogenicity island, which contains genes for virulence and avirulence, on a large native plasmid in the bean pathogen Pseudomonas syringae pathovar phaseolicola. Proc Natl Acad Sci U S A (1999) 2.39
Pancreatography in chronic pancreatitis: international definitions. Gut (1984) 2.37
Early gastric cancer in Europe. Gut (1997) 2.34
Chronic gastritis--a pathogenetic approach. J Pathol (1988) 2.31
Histological identification of Helicobacter pylori: comparison of staining methods. J Clin Pathol (2000) 2.31
Multiplexed single nucleotide polymorphism genotyping by oligonucleotide ligation and flow cytometry. Cytometry (2000) 2.30
Effect of duodenal ulcer surgery and enterogastric reflux on Campylobacter pyloridis. Lancet (1986) 2.27
Genetic abnormalities during transition from Helicobacter-pylori-associated gastritis to low-grade MALToma. Lancet (1995) 2.21
Disodium cromoglycate in the treatment of chronic proctitis. Gut (1975) 2.21
An analysis of the reliability of detection and diagnostic value of various pathological features in Crohn's disease and ulcerative colitis. Gut (1973) 2.21
Effect of cimetidine on the gastric bacterial flora. Lancet (1980) 2.18
Reappraisal of the 5 centimetre rule of distal excision for carcinoma of the rectum: a study of distal intramural spread and of patients' survival. Br J Surg (1983) 2.17
Functional homologs of the Arabidopsis RPM1 disease resistance gene in bean and pea. Plant Cell (1992) 2.15
Intestinal permeability assessed by excretion ratios of two molecules: results in coeliac disease. Br Med J (1978) 2.12
Early gastric cancer: 46 cases treated in one surgical department. Gut (1992) 2.10
Local immune response to gastric Campylobacter in non-ulcer dyspepsia. J Clin Pathol (1986) 2.03
A microsphere-based assay for multiplexed single nucleotide polymorphism analysis using single base chain extension. Genome Res (2000) 2.00
One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group. Gut (1997) 2.00
Campylobacter-like organisms unusual in type A (pernicious anaemia) gastritis. Lancet (1984) 2.00
PCR identification of Helicobacter pylori in faeces from gastritis patients. Lancet (1993) 2.00
Campylobacter like organisms and reflux gastritis. J Clin Pathol (1986) 1.99
Dyspepsia: a dilemma for doctors? Lancet (1987) 1.96
Randomised controlled trial of azathioprine withdrawal in ulcerative colitis. BMJ (1992) 1.94
Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther (2002) 1.94
Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology. Br J Cancer (1993) 1.93
Immune response of the gastric mucosa to Campylobacter pylori. Scand J Gastroenterol Suppl (1988) 1.93
Microsatellite instability in colorectal cancer: improved assessment using fluorescent polymerase chain reaction. Gastroenterology (1995) 1.92
Flat adenomas in the United Kingdom: are treatable cancers being missed? Endoscopy (1998) 1.92
Open access upper gastrointestinal endoscopy. BMJ (1993) 1.91
Fluorescent microsphere-based readout technology for multiplexed human single nucleotide polymorphism analysis and bacterial identification. Hum Mutat (2001) 1.89
Immune response to Campylobacter pyloridis. Lancet (1985) 1.86
Immune responses to Helicobacter pylori in children with recurrent abdominal pain. J Clin Pathol (1991) 1.84
Gastric cancer, cytotoxin-associated gene A-positive Helicobacter pylori, and serum pepsinogens: an international study. The Eurogst Study Group. Gastroenterology (1999) 1.83